Dizocilpine does not prevent the development of tolerance to the anxiolytic effects of diazepam in rats.
The non-competitive NMDA receptor antagonist, dizocilpine (0.25 mg/kg), has previously been shown to block the development of tolerance to the sedative effects of diazepam (2 mg/kg). Since there is considerable evidence that different mechanisms underlie the development of tolerance to the sedative and anxiolytic effects of diazepam, the present experiment examined whether dizocilpine would block the development of tolerance to diazepam's anxiolytic effects. Rats tested after an acute dose of diazepam (2 mg/kg) showed an anxiolytic effect, measured by an increase in the time spent in social interaction, whereas those tested after 21 days of treatment had scores equal to the control group. This development of tolerance was not blocked by concomitant administration of dizocilpine (0.25 mg/kg). Thus, these results provide further evidence that the mechanism underlying tolerance to the anxiolytic effects of diazepam is different from that underlying tolerance to the sedative effects.
Fernandes
C
C
Psychopharmacology Research Unit, Neuroscience Research Centre, GKT School of Biomedical Sciences, King's College London, Hodgrin Building, Guy's Campus, London, SE1 9RT, UK.
File
S E
SE
D000818:Animals; D014151:Anti-Anxiety Agents / Q000008:administration & dosage*; D001522:Behavior, Animal / Q000187:drug effects; D003975:Diazepam / Q000008:administration & dosage*; D016291:Dizocilpine Maleate / Q000008:administration & dosage*; D004361:Drug Tolerance; D007274:Injections, Intraperitoneal; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D012919:Social Behavior
D014151:Anti-Anxiety Agents; D016291:Dizocilpine Maleate; D003975:Diazepam